Mostly efficient domain content, but it re-explains concepts Claude already knows (e.g. 'Shannon entropy: Overall diversity (higher = more diverse)', definitions of convergent recombination and Gini coefficient) and the Domain Reasoning / Interpretation Guidance sections could be tightened; not score 3 because not every token earns its place, and not score 1 because the bulk is actionable domain knowledge rather than generic filler.

Concrete tool calls with real parameters (e.g. 'BVBRC_search_epitopes' with taxon_id="2697049", 'sequence_contains' for motif search) are strong, but the Quick Start relies on undefined helper functions (load_airr_data, define_clonotypes, calculate_diversity, detect_expanded_clones, query_epitope_database) that are effectively pseudocode and not copy-paste executable; not score 3 because the code is not fully executable, and not score 1 because there is genuine concrete guidance beyond vague direction.

An 8-phase workflow is clearly sequenced with verification guidance (rarefaction plateau checks, an evidence-grading table, and synthesis questions); this is a read-only analysis workflow so the destructive/batch validation cap does not apply, and not score 2 because checkpoints are explicit rather than merely implicit.

The 'See Also' section signals one-level-deep references (ANALYSIS_DETAILS.md, USE_CASES.md), but those files do not exist in the bundle and substantial detail is inlined in SKILL.md that could be split out; not score 3 because the referenced files are missing and the split is incomplete, and not score 1 because references are clearly signaled rather than deeply nested.

Lists multiple concrete actions — 'V(D)J segment usage, CDR3 sequence diversity, clonality scoring, antigen specificity matching to IEDB, public-clone identification' — matching the anchor for multiple specific concrete actions, and is comprehensive rather than partial, so it is not the level below.

Clearly answers both what (the analysis capabilities) and when via an explicit 'Use for adaptive immune response characterization, post-treatment immune monitoring...' clause; it is not the level below because the when is explicit, not merely implied.

Natural domain terms a practitioner would actually say — 'TCR/BCR repertoire analysis', 'clonality scoring', 'clonal-expansion analysis', 'immune monitoring', 'immunotherapy or vaccination studies' — give good coverage; not the level below because common variations are present rather than just one keyword.

A clear niche (TCR/BCR immune repertoire analysis) with distinct triggers unlikely to fire for unrelated skills; not the level below because the domain and triggers are specific, not generic.